86 - Clinical Response (HbA1C ≥1% and/or Body Weight ≥5% Reduction) to Semaglutide by Baseline HbA1C and Body Weight in the SUSTAIN Program

Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7, SupplementAuthor(s): Akshay Jain, Vanita R. Aroda, Julie F. Larsen, Signe Harring Østoft, Rosangela R. Rea, Danny Sugimoto, Uwe Ziegler, Tina Vilsbøll
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research